GenScript Biotech Corp Reports Strong FY2025 Results as Integrated Platform Strategy and Global Execution Drive High-Quality Growth

Go back to GenScript Biotech Corp Reports Strong FY2025 Results as Integrated Platform Strategy and Global Execution Drive High-Quality Growth
(NASDAQ: LEGN) Delayed: 28.69 +0.26 (0.91%)
Previous Close $28.43    52 Week High
Open $28.08    52 Week Low
Day High $29.32    P/E N/A 
Day Low $27.89    EPS
Volume 2,829,042